Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Optas LLC

Optas LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.1% during the fourth quarter, HoldingsChannel reports. The fund owned 795 shares of the medical equipment provider’s stock after buying an additional 144 shares during the period. Optas LLC’s holdings in Intuitive Surgical were worth $415,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock valued at $15,357,560 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $578.55 on Tuesday. The stock has a market capitalization of $206.07 billion, a P/E ratio of 90.26, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business’s 50-day simple moving average is $550.40 and its 200-day simple moving average is $510.02.

Wall Street Analyst Weigh In

Several research firms recently issued reports on ISRG. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.